Who will be eligible? An investigation of the dementia population eligible for cholinesterase treatment following the change in NICE guidance. (2010)
Attributed to:
Statistical modelling of cognitive decline to improve estimation, identifying risk factors and population benefits.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1002/gps.2413
PubMed Identifier: 19946863
Publication URI: http://europepmc.org/abstract/MED/19946863
Type: Journal Article/Review
Volume: 25
Parent Publication: International journal of geriatric psychiatry
Issue: 7
ISSN: 0885-6230